Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda

Acta Tropica

Volumn 121, Issue 1, 2012, Pages 50-54

  Zeile, Irene ^a   Gahutu, Jean Bosco ^b   Shyirambere, Cyprien ^b   Steininger, Christian ^a   Musemakweri, Andre ^b   Sebahungu, Fidèle ^c   Karema, Corine ^c   Harms, Gundel ^a   Eggelte, Teunis A ^d   Mockenhaupt, Frank P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF RWANDA   (Rwanda)

^c TRAC Plus   (Rwanda)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Drug resistance; Malaria; Pfmdr1; Rwanda; Sulfadoxine pyrimethamine

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; MOLECULAR MARKER; PYRIMETHAMINE;

ALLELE; BIOASSAY; DRUG RESISTANCE; MALARIA; MUTATION; PARASITE; PLASMA; POLYMORPHISM; PROTOZOAN;

ALLELE; ARTICLE; CHILD; DIHYDROFOLATE REDUCTASE GENE; DIHYDROPTEROATE SYNTHASE GENE; DRUG BLOOD LEVEL; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; HUMAN; MALARIA FALCIPARUM; MALE; MULTIPLE DRUG RESISTANCE 1 GENE; MUTATIONAL ANALYSIS; MUTATOR GENE; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RWANDA;

ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MUTATION, MISSENSE; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; PYRIMETHAMINE; RWANDA;

RWANDA;

PLASMODIUM FALCIPARUM;

EID: 81255160736     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.09.009     Document Type: Article

References (38)

1. Alker A.P., Lim P., Sem R., Shah N.K., Yi P., Bouth D.M., Tsuyuoka R., Maguire J.D., Fandeur T., Ariey F., Wongsrichanalai C., Meshnick S.R. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am. J. Trop. Med. Hyg. 2007, 76:641-647.
2. Aponte J.J., Schellenberg D., Egan A., Breckenridge A., Carneiro I., Critchley J., Danquah I., Dodoo A., Kobbe R., Lell B., May J., Premji Z., Sanz S., Sevene E., Soulaymani-Becheikh R., Winstanley P., Adjei S., Anemana S., Chandramohan D., Issifou S., Mockenhaupt F.P., Owusu-Agyei S., Greenwood B., Grobusch M.P., Kremsner P.G., Macete E., Mshinda H., Newman R.D., Slutsker L., Tanner M., Alonso P., Menendez C. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 2009, 374:1533-1542.
3. Bonizzoni M., Afrane Y., Baliraine F.N., Amenya D.A., Githeko A.K., Yan G. Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya. Infect. Genet. Evol. 2009, 9:806-812.
4. de Monbrison F., Raynaud D., Latour-Fondanaiche C., Staal A., Favre S., Kaiser K., Peyron F., Picot S. Real-time PCR for chloroquine sensitivity assay and for pfmdr1-pfcrt single nucleotide polymorphisms in Plasmodium falciparum. J. Microbiol. Methods 2003, 54:391-401.
5. Djimdé A., Doumbo O.K., Cortese J.F., Kayentao K., Doumbo S., Diourté Y., Dicko A., Su X.Z., Nomura T., Fidock D.A., Wellems T.E., Plowe C.V., Coulibaly D. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 2001, 344:257-263.
6. Djimde A.A., Dolo A., Ouattara A., Diakite S., Plowe C.V., Doumbo O.K. Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. J. Infect. Dis. 2004, 190:853-855.
7. Dokomajilar C., Nsobya S.L., Greenhouse B., Rosenthal P.J., Dorsey G. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob. Agents Chemother. 2006, 50:1893-1895.
8. Duraisingh M.T., Curtis J., Warhurst D.C. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp. Parasitol. 1998, 89:1-8.
9. East African Network for Monitoring Antimalarial Treatment (EANMAT) The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop. Med. Int. Health 2003, 8:860-867.
10. Eggelte T.A. Production of monoclonal antibodies against antimalarial drugs for use in immunoassays. The Validation of Chemical and Immunochemical Tests for Antimalarials in Body Fluids. International Monograph Series 3 1990, 35-63. Universiti Sains Malaysia, Penang, Malaysia. V. Navaratnam, D. Payne (Eds.).
11. Fanello C.I., Karema C., van Doren W., van Overmeir C., Ngamije D., D'Alessandro U. A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:344-350.
12. Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M., Sidhu A.B., Naudé B., Deitsch K.W., Su X.Z., Wootton J.C., Roepe P.D., Wellems T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 2000, 6:861-871.
13. Gahutu J.B., Steininger C., Shyirambere C., Zeile I., Cwinya-Ay N., Danquah I., Larsen C.H., Eggelte T.A., Uwimana A., Karema C., Musemakweri A., Harms G., Mockenhaupt F.P. Prevalence and risk factors of malaria among children in southern highland Rwanda. Malar. J. 2011, 10:134.
14. Gesase S., Gosling R.D., Hashim R., Ord R., Naidoo I., Madebe R., Mosha J.F., Joho A., Mandia V., Mrema H., Mapunda E., Savael Z., Lemnge M., Mosha F.W., Greenwood B., Roper C., Chandramohan D. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS ONE 2009, 4:e4569.
15. Happi C.T., Gbotosho G.O., Folarin O.A., Sowunmi A., Hudson T., O'Neil M., Milhous W., Wirth D.F., Oduola A.M. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 2009, 53:888-895.
16. Holmgren G., Björkman A., Gil J.P. Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya. Trop. Med. Int. Health 2006, 11:1808-1812.
17. Holmgren G., Gil J.P., Ferreira P.M., Veiga M.I., Obonyo C.O., Björkman A. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect. Genet. Evol. 2006, 6:309-314.
18. Humphreys G.S., Merinopoulos I., Ahmed J., Whitty C.J., Mutabingwa T.K., Sutherland C.J., Hallett R.L. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob. Agents Chemother. 2007, 51:991-997.
19. Imwong M., Dondorp A.M., Nosten F., Yi P., Mungthin M., Hanchana S., Das D., Phyo A.P., Lwin K.M., Pukrittayakamee S., Lee S.J., Saisung S., Koecharoen K., Nguon C., Day N.P., Socheat D., White N.J. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob. Agents Chemother. 2010, 54:2886-2892.
20. Karema C., Imwong M., Fanello C.I., Stepniewska K., Uwimana A., Nakeesathit S., Dondorp A., Day N.P., White N.J. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob. Agents Chemother. 2010, 54:477-483.
21. Kublin J.G., Dzinjalamala F.K., Kamwendo D.D., Malkin E.M., Cortese J.F., Martino L.M., Mukadam R.A., Rogerson S.J., Lescano A.G., Molyneux M.E., Winstanley P.A., Chimpeni P., Taylor T.E., Plowe C.V. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 2002, 185:380-388.
22. Kublin J.G., Cortese J.F., Njunju E.M., Mukadam R.A., Wirima J.J., Kazembe P.N., Djimdé A.A., Kouriba B., Taylor T.E., Plowe C.V. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 2003, 187:1870-1875.
23. Laufer M.K., Thesing P.C., Eddington N.D., Masonga R., Dzinjalamala F.K., Takala S.L., Taylor T.E., Plowe C.V. Return of chloroquine antimalarial efficacy in Malawi. N. Engl. J. Med. 2006, 355:1959-1966.
24. Mita T., Kaneko A., Lum J.K., Zungu I.L., Tsukahara T., Eto H., Kobayakawa T., Björkman A., Tanabe K. Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol. Biochem. Parasitol. 2004, 135:159-163.
25. Mugittu K., Ndejembi M., Malisa A., Lemnge M., Premji Z., Mwita A., Nkya W., Kataraihya J., Abdulla S., Beck H.P., Mshinda H. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. Am. J. Trop. Med. Hyg. 2004, 71:696-702.
26. Mwai L., Kiara S.M., Abdirahman A., Pole L., Rippert A., Diriye A., Bull P., Marsh K., Borrmann S., Nzila A. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob. Agents Chemother. 2009, 53:5069-5073.
27. Nawaz F., Nsobya S.L., Kiggundu M., Joloba M., Rosenthal P.J. Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda. J. Infect. Dis. 2009, 200:1650-1657.
28. Nkhoma S., Nair S., Mukaka M., Molyneux M.E., Ward S.A., Anderson T.J. Parasites bearing a single copy of the multi-drug resistance gene (pfmdr-1) with wild-type SNPs predominate amongst Plasmodium falciparum isolates from Malawi. Acta Trop. 2009, 111:78-81.
29. Price R.N., Cassar C., Brockman A., Duraisingh M., van Vugt M., White N.J., Nosten F., Krishna S. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 1999, 43:2943-2949.
30. Price R.N., Uhlemann A.C., van Vugt M., Brockman A., Hutagalung R., Nair S., Nash D., Singhasivanon P., Anderson T.J., Krishna S., White N.J., Nosten F. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 2006, 42:1570-1577.
31. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000, 403:906-909.
32. Rogerson S.J., Chaluluka E., Kanjala M., Mkundika P., Mhango C., Molyneux M.E. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:549-553.
33. Rubio J.M., Post R.J., van Leeuwen W.M., Henry M.C., Lindergard G., Hommel M. Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR). Trans. R. Soc. Trop. Med. Hyg. 2002, 96(Suppl. 1):S199-S204.
34. Sisowath C., Strömberg J., Mårtensson A., Msellem M., Obondo C., Björkman A., Gil J.P. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 2005, 191:1014-1017.
35. Sisowath C., Petersen I., Veiga M.I., Mårtensson A., Premji Z., Björkman A., Fidock D.A., Gil J.P. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J. Infect. Dis. 2009, 199:750-757.
36. Somé A.F., Séré Y.Y., Dokomajilar C., Zongo I., Rouamba N., Greenhouse B., Ouédraogo J.B., Rosenthal P.J. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso. Antimicrob. Agents Chemother. 2010, 54:1949-1954.
37. Sridaran S., McClintock S.K., Syphard L.M., Herman K.M., Barnwell J.W., Udhayakumar V. Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Malar. J. 2010, 9:247.
38. Uhlemann A.C., Ramharter M., Lell B., Kremsner P.G., Krishna S. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J. Infect. Dis. 2005, 192:1830-1835.